γδ T cells for cancer immunotherapy: A systematic review of clinical trials
about
Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescentsEmpowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapyRegeneration of stalled immune responses to transformed and infected cells using γδ T cellsDirect and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationImmunotherapy in human colorectal cancer: Challenges and prospectiveHaploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyKey Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.Clinical applications of gamma delta T cells with multivalent immunity.Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cellsγδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis2015 Guidance on cancer immunotherapy development in early-phase clinical studies.Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronateRhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsγδ T Cell-Mediated Immunity to Cytomegalovirus Infection.Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulationLow-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.γδ T Cell-Mediated Immune Responses in Disease and Therapyγδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors.Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients.Apoptosis Induced via Gamma Delta T Cell Antigen Receptor "Blocking" Antibodies: A Cautionary TaleEditorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance.Immunosuppressive γδ T cells foster pancreatic carcinogenesis.Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells.Integration of oncogenes via Sleeping Beauty as a mouse model of HPV16+ Oral tumor and immunologic control.Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).
P2860
Q26750995-B7D8231C-9B14-4CA9-84FE-3379274FD299Q26781175-D213CBE4-48A7-4CD7-A028-2708D33561E8Q26823185-73C5C398-A754-486A-B83F-62F3AC18A2D1Q26863724-8705B665-CA77-482B-9BA2-977854515B13Q28068788-B9B9A564-DA87-4C40-AF08-DE2818756306Q28085397-4C0FA2A3-6508-4C5C-93F9-3DDD810F944BQ33855566-C93F770E-5D6D-4671-9922-4950D39E0EBFQ34502154-E44718CD-D419-4DB7-A39B-920E971D9AA7Q34677859-CA69331E-D6A3-4E40-A6AA-258598B872FBQ35677421-5084CA83-08E3-4D4F-9BE9-4E37552B6DEAQ35799192-4AAA9499-38B8-4213-A850-D71F13B44176Q35803534-D0920DEF-6ED4-43B4-B901-A1637A2B4339Q35935862-3279D225-12C2-4314-BE39-7BB624B260C6Q35937473-550A1A71-3F6D-4BB3-AB3D-9A9AA2E05BA0Q36467378-9ED9A369-9E8B-4C93-A8B3-08A1A45872C2Q36597374-13D2EDF0-0971-4FCB-A417-DDDFE238F2ADQ36734208-7D0A4ECC-3245-4060-B1B0-BD0331760FE6Q37279963-7F0EE523-37AD-4416-A3A1-D8392AC9EBB2Q37294760-7A487353-5CFE-45D8-9B8F-BC4E5AA279C6Q37632938-624238BD-3818-4F2E-B90C-C4A0EC8E0A34Q37655345-C4FC1C6D-9ED3-4A24-ACFA-D1CA681C06A3Q37701514-723EC3EE-57C3-451B-97F8-163D8DF47D61Q38271584-EE096980-73BD-4368-A83A-3375E08D7CE1Q38271585-52D04172-3FA7-4A18-9C57-59C369FA60F4Q38283536-B9727DE1-3A4A-4B0E-A38B-10815681FF28Q38730126-F06B465B-EAA9-41E9-8CD1-B510C0E962A6Q38839878-9A3A141A-CEB5-45ED-9886-6563E6F6C101Q39195619-FA4B2A18-CED3-49E1-86F9-52513E70BE0AQ39832849-54B323CD-5086-4776-B81F-E02DA0738918Q40267794-F6745CF9-7054-4E10-90C7-8764CE62457CQ40808689-096FC010-F879-425F-9D13-590D67DEEE85Q40989863-8A01C672-3C9B-440A-B87A-B415AA9DC834Q41061926-CE4625BD-0113-4578-B6DD-C2D3C9153644Q41118007-81E21971-4364-47E9-96AF-6EE7631C8C04Q42357971-C391B5E3-D33E-4507-84C7-5085751F6F34Q47146669-CB0BBDF3-6EBA-49EF-843D-2F0C69D91698Q47549568-E9D15F3B-37A7-41AC-98D1-4C5C1FBE198CQ48128395-EB8D3B46-89AE-4E61-80F2-589437C612D2Q48359042-6E08844D-0B75-4DBE-AF3E-6837216ADB70Q49333274-A5A9D25C-2CC9-4625-A0DC-560CEB82CB64
P2860
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@ast
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@en
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@nl
type
label
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@ast
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@en
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@nl
prefLabel
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@ast
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@en
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@nl
P2093
P2860
P3181
P356
P1433
P1476
γδ T cells for cancer immunotherapy: A systematic review of clinical trials
@en
P2093
Jennifer Heuijerjans
John Anderson
Kenth Gustafsson
Mengyong Yan
P2860
P304
P3181
P356
10.4161/ONCI.27572
P577
2014-01-17T00:00:00Z